Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid Consumption, Postoperative × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3070 Neoplasms 2448 Carcinoma, Non-Small-Cell Lung 1854 Prostatic Neoplasms 1617 Colorectal Neoplasms 1368 Lung Neoplasms 1265 Neoplasm Metastasis 925 Multiple Myeloma 922 Leukemia, Myeloid, Acute 883 Pancreatic Neoplasms 857 Ovarian Neoplasms 799 Melanoma 785 Carcinoma, Hepatocellular 732 Stomach Neoplasms 647 Recurrence 645 Squamous Cell Carcinoma of Head and Neck 640 Brain Neoplasms 627 Head and Neck Neoplasms 594 Glioblastoma 551 Lymphoma 548 Uterine Cervical Neoplasms 540 Precursor Cell Lymphoblastic Leukemia-Lymphoma 515 Triple Negative Breast Neoplasms 511 Carcinoma, Renal Cell 502 Hematologic Neoplasms 473 Endometrial Neoplasms 461 Urinary Bladder Neoplasms 455 Colonic Neoplasms 454 Lymphoma, Non-Hodgkin 440 Sarcoma 428

Interventions

Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07263165 2025-12-04

Dexmedetomidin

Assiut University

Phase NA Not yet recruiting

Opioid Consumption, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡